Trial Profile
Safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in liver transplant patients with recurrent hepatits C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2016 New trial record